Influence
May 14, 2020

In New York Times opinion piece, Regenstrief VP presents COVID-19 data recommendations for states

As states are beginning to reopen in the face of COVID-19, many are doing so without enough data, according to Regenstrief Institute Vice President for Faculty and Development Aaron Carroll, M.D. In a recent opinion column for the New York Times, Dr. Carroll made an exception: Indiana.

He discussed the groundbreaking COVID-19 testing study being led by Regenstrief research scientist and IU Fairbanks School of Public Health faculty member Nir Menachemi, PhD, MPH.

The study, which tested 4,600 people in its first phase, has found that 2.8 percent of Hoosiers are either infected with the coronavirus or have recovered. While these findings suggested a mortality rate of about 0.6 percent, lower than some experts have suggested, the study also indicated that 10 out of 11 cases of COVID-19 in the state’s population are not being caught due to low testing rates.

“We need much more data,” Dr. Carroll writes, “too many states are flying blind, moving ahead without understanding their risk. There’s no excuse for that. There’s no magic to what’s just been done in Indiana. All states could do it if they just committed to it.”

Since early in the pandemic, Dr. Carroll has warned about the potential of the virus to overwhelm the healthcare system and has been an advocate for nationwide social distancing and mass testing of the population as a means to contain the virus.

READ THE ARTICLE

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher